HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Nasopharyngeal Cancer

Nasopharyngeal Cancer

Nasopharyngeal cancer, a rare form of head and neck cancer, arises in the nasopharynx, the upper part of the throat behind the nose. Research in this field focuses on understanding the disease's molecular mechanisms, risk factors, and improving treatment outcomes. Key areas of investigation include exploring the role of Epstein-Barr virus (EBV) infection, genetic predisposition, and environmental factors such as diet and tobacco use in cancer development. Innovative therapies such as immunotherapy and targeted molecular treatments are being studied to enhance treatment efficacy and reduce side effects. Early detection methods, including advanced imaging techniques and biomarker identification, are also under scrutiny to improve prognosis and survival rates. Collaborative efforts between clinicians, researchers, and pharmaceutical companies drive progress in combating this challenging cancer type.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Atif A Ahmed

Atif A Ahmed

Seattle Children’s Hospital, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
CIOC 2027 Speakers
Thomas Jay Webster

Thomas Jay Webster

Brown University, United States
Eleni Petsalaki

Eleni Petsalaki

University of Crete, Greece
Saumya Pandey

Saumya Pandey

Indira IVF Hospital, India

Submit your abstract Today

YouTube
WhatsAppWhatsApp